Taligen Therapeutics

Taligen Therapeutics

Verified
Focused on the R&D of novel protein therapeutics for the treatment of inflammatory conditions and diseases

Launch date
Employees
Market cap
-
Net debt
-
Firm valuation
$111m (Public information from Jan 2011)
Cambridge Massachusetts (HQ)
  • Edit
DateInvestorsAmountRound
-N/A-
Not yet verified
$3.8mSeries A
N/A$65mSeries B
N/A$10mSeries B
$111m
Valuation: $111m
Acquisition
Total Funding$78.8m

Recent News about Taligen Therapeutics

Edit